The North America hormone replacement therapy market size reached US$ 4.5 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 6.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2023-2032
Hormone replacement therapy (HRT) is used for replenishing hormones that are present in low levels in the human body. This treatment is particularly favorable for patients who are experiencing growth hormone deficiency, women nearing menopause and older people suffering from hypogonadism. HRT is available in several forms such as gels, injections, implants, and skin and mouth patches (transdermal). However, it may not be suitable for patients that have a record of blood clots, liver disease and untreated high blood pressure.
North America hormone replacement therapy market is currently being driven by several factors. A surge in the incidences of hormone imbalance disorders, especially in the geriatric and neonatal populations, is spurring the demand for HRT in North America. In line with this, the rising need for new treatment options with better safety results is further catalyzing the market growth in the region. Apart from this, increasing R&D activities for hormone replacement products is enhancing their quality and efficiency. Additionally, the increasing consumer awareness, coupled with the rising technological innovations, such as new gel-based formulations, have also spurred the demand for hormone replacement products in the region.
Hormone replacement therapy (HRT) is used for replenishing hormones that are present in low levels in the human body. This treatment is particularly favorable for patients who are experiencing growth hormone deficiency, women nearing menopause and older people suffering from hypogonadism. HRT is available in several forms such as gels, injections, implants, and skin and mouth patches (transdermal). However, it may not be suitable for patients that have a record of blood clots, liver disease and untreated high blood pressure.
North America hormone replacement therapy market is currently being driven by several factors. A surge in the incidences of hormone imbalance disorders, especially in the geriatric and neonatal populations, is spurring the demand for HRT in North America. In line with this, the rising need for new treatment options with better safety results is further catalyzing the market growth in the region. Apart from this, increasing R&D activities for hormone replacement products is enhancing their quality and efficiency. Additionally, the increasing consumer awareness, coupled with the rising technological innovations, such as new gel-based formulations, have also spurred the demand for hormone replacement products in the region.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the North America hormone replacement therapy market report, along with forecasts at the regional and country level from 2024-2032. The report has categorized the market based on product, route of administration and type of disease.- Key Regions Analysed
- United States
- Canada
- Mexico
- Analysis for Each Country
Market by Product
- Estrogen Replacement Therapy
- Human Growth Hormone Replacement Therapy
- Thyroid Replacement Therapy
- Testosterone Replacement Therapy
- Others
Market by Route of Administration
- Oral
- Parenteral
- Transdermal
Market by Type of Disease
- Menopause
- Hypothyroidism
- Male Hypogonadism
- Growth Hormone Deficiency
- Others
- Value Chain Analysis
- Key Drivers and Challenges
- Porters Five Forces Analysis
- PESTEL Analysis
- Government Regulations
- Competitive Landscape
- Competitive Structure
- Key Player Profiles
Key Questions Answered in This Report:
- How has the North America hormone replacement therapy market performed so far and how will it perform in the coming years?
- What are the key regions in the North America hormone replacement therapy market?
- What has been the impact of COVID-19 on the North America hormone replacement therapy market?
- What is the breakup of the North America hormone replacement therapy market on the basis of product?
- What is the breakup of the North America hormone replacement therapy market on the basis of route of administration?
- What is the breakup of the North America hormone replacement therapy market on the basis of type of disease?
- What are the various stages in the value chain of the North America hormone replacement therapy industry?
- What are the key driving factors and challenges in the North America hormone replacement therapy industry?
- What is the structure of the North America hormone replacement therapy industry and who are the key players?
- What is the degree of competition in the North America hormone replacement therapy industry?
Table of Contents
1 Preface3 Executive Summary
2 Scope and Methodology
4 Introduction
5 Global Hormone Replacement Therapy Market
6 North America Hormone Replacement Therapy Market
7 North America Hormone Replacement Therapy Market: Breakup by Product
8 North America Hormone Replacement Therapy Market: Breakup by Route of Administration
9 North America Hormone Replacement Therapy Market: Breakup by Type of Disease
10 North America Hormone Replacement Therapy Market: Breakup by Country
11 SWOT Analysis
12 Value Chain Analysis
13 Porter’s Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 124 |
| Published | March 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 4.5 Billion |
| Forecasted Market Value ( USD | $ 6.9 Billion |
| Compound Annual Growth Rate | 4.9% |
| Regions Covered | North America |
